This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Allosteros Therapeutics, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Sampath K Nangunoori
Introduction
Sampath K Nangunoori is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for specific protein kinases. His work has implications for various therapeutic applications.
Latest Patents
Sampath holds a patent for "CaMKII inhibitors and uses thereof." This invention provides compounds that are useful as inhibitors of Ca/calmodulin-dependent protein kinase (CaMKII), along with compositions and methods for their use. This patent highlights his innovative approach to addressing complex biochemical challenges.
Career Highlights
Sampath is currently associated with Allosteros Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company focuses on creating novel therapeutic solutions that can impact patient care positively.
Collaborations
He has collaborated with notable colleagues, including Daniel Emil Levy and Howard Schulman. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Sampath K Nangunoori's contributions to the field of biochemistry through his patent and work at Allosteros Therapeutics, Inc. demonstrate his commitment to innovation and the advancement of medical science. His efforts are paving the way for new therapeutic options in the treatment of various conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile